Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 1 Interventional

Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis

ClinicalTrials.gov ID: NCT02576457

Public ClinicalTrials.gov record NCT02576457. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Subjects With Severe Sepsis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether BMS-936559 is safe and has the desired pharmacologic activity in patients who have severe sepsis.

Study identification

NCT ID
NCT02576457
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
35 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2, 2015 (Actual)
Primary completion
Mar 15, 2017 (Actual)
Completion
Mar 15, 2017 (Actual)
Last update posted
Sep 15, 2017

2015 – 2017

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Uc Davis Medical Center Sacramento California 95817 —
Local Institution Denver Colorado 80204 —
University Of Florida Gainesville Florida 32610 —
Emory University Atlanta Georgia 30322 —
Osf Saint Francis Medical Center Peoria Illinois 61637 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Baystate Medical Center Springfield Massachusetts 01199 —
University of Michigan, Division of Acute Care Surgery Ann Arbor Michigan 48109-5033 —
Washington University School Of Medicine St Louis Missouri 63110 —
The Ohio State University Columbus Ohio 43210 —
St. Vincent'S Medical Center Toledo Ohio 43603 —
UPMC Pittsburgh Pennsylvania 15261-2500 —
Local Institution Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02576457, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2017 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02576457 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →